Navigation Links
Arthritis Foundation bestows prestigious national research award
Date:12/1/2008

ATLANTA, Dec. 1, 2008 The Arthritis Foundation announces the 2008 winners of the Lee C. Howley Sr. Prize for research in arthritis. The recipients, Dr. Gerard Karsenty of the Columbia University College of Physicians and Dr. Michel Nussenzweig of Rockefeller University received the award for their continued research advancements in the cure and control of rheumatic diseases.

Dr. Karsenty is recognized for his research in the development and function of the skeletal system. A graduate of the University of Paris, Dr. Karsenty received his postdoctoral fellow in the laboratory of Dr. Benoit de Crombrugghe. Prior to Dr. Karsenty's work, little was known about the molecular basis of mammalian skeletal system development and differentiation. Now, a decade later, the field is burgeoning with a plethora of new transcription factors, coactivators, corepressors, and signaling pathways that explain the development of the osteoblast from the mesenchymal stem cell, both during embryonic development and during postnatal bone formation. Dr. Karsenty is currently the Paul. A. Marks M.D. Professor and Chairman of the Department of Genetics and Development at Columbia University College of Physicians and Surgeons in New York City.

Dr. Nussenzweig is recognized for his contributions to the fields of B cell development and dendritic cell function. These studies have been crucial in providing insights into the etiology of autoimmune diseases such as rheumatoid arthritis and have paved the way to the development of novel therapies for the treatment of these diseases. After completing a medical internship, residency, and infectious disease fellowship at the Massachusetts General Hospital, Dr. Nussenzweig joined Dr. Philip Leder in the department of genetics at Harvard Medical School for postdoctoral training. Dr. Nussenzweig currently heads the laboratory of Molecular Immunology at Rockefeller University.


'/>"/>

Contact: Carol Galbreath
cgalbreath@arthritis.org
404-965-7595
Arthritis Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Arthritis Foundation Renews Comprehensive Marketing Contract with Merkle
2. New Therapy Could Transform Arthritis Treatment
3. The SCOOTER Store Donates Power Wheelchair to Former Manassas Detective Stricken With Arthritis
4. Medicaid policies vary widely for rheumatoid arthritis drugs
5. Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered
6. Arthritis Foundation Honors Comerica Bank at Commitment To A Cure Awards Gala
7. Biologics Dont Raise Cancer Risk in Rheumatoid Arthritis Patients
8. Rheumatoid Arthritis May Harm Gums
9. New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers
10. Rheumatoid Arthritis a Threat to the Heart
11. Rheumatoid Arthritis Rising Among U.S. Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal safety ... the end of November. , The Chicago, Illinois, based self-defense brand has been waiting ... about the ease of taking their personal safety into their own hands. , The ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and ... departments have been awarded five-year accreditation status through the Public Health Accreditation ... served by a PHAB-accredited health department now extend to more than 203 ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... right or exercise more try taking a more holistic approach and use natural ... new Amazon essential oil collection is certified USDA guaranteeing that, the new line ...
(Date:9/21/2017)... Mass. (PRWEB) , ... September 21, 2017 , ... The ... children with autism, announced today the election of Yie-Hsin Hung to the Board of ... Hung join our Board of Directors. Ms. Hung is an invaluable addition to our ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: